Please login to the form below
pain
This page shows the latest pain news and features for those working in and with pharma, biotech and healthcare.
New blood test to reduce heart attacks and death rates in A&E heart patients
people with chest pains and related symptoms.
Latest news
-
FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours
Each year, an estimated 1, 650 people in the US are diagnosed with desmoid tumours, which may invade surrounding structures and organs, resulting in pain, mobility issues and decreased quality of ... Saqib Islam, chief executive officer of SpringWorks,
-
Valneva’s chikungunya vaccine approved by FDA for adults at increased exposure risk
Infection leads to symptomatic disease in up to 97% of people after three to seven days following the mosquito bite, with clinical symptoms including fever, joint and muscle pain, headache, nausea
-
Janssen reports positive real-world data for Tremfya in psoriatic arthritis
Affecting approximately ten million people worldwide, psoriatic arthritis is a chronic immune-mediated inflammatory disease characterised by joint pain, stiffness and swelling. ... in pain, physical function and fatigue through six months, which Janssen
-
Janssen reveals positive results for nipocalimab in rheumatoid arthritis
Approximately 13 million people worldwide are affected by RA, a chronic inflammatory disease that causes joint pain, swelling and stiffness, and in some cases, permanent damage and deformity in structural joint
-
International study reveals how to measure long COVID severity and impact
Long COVID occurs when symptoms including fatigue, shortness of breath, pain, exercise intolerance and cognitive dysfunction, persist or develop after COVID-19.
More from news
Approximately 17 fully matching, plus 947 partially matching documents found.
Latest Intelligence
-
Neuromyelitis optica spectrum disorder: is there hope on the horizon?
FP:Both diseases can manifest with similar features and symptoms, like vision loss caused by optic neuritis and myelitis, as well as pain policies and other ambulation problems. ... NMOSD has a host of symptoms that can impact patients’ lives,
-
What does launch excellence really mean? For you? For your customers? For their patients!
Only here can we really elevate and evolve launch excellence, overcoming audience barriers such as HCP and patient habits, perceptions and entrenched behaviours, as well as internal pain points ranging across
-
The five ‘innovation areas’ driving success in chronic diseases
For example, the recently US Food and Drug Administration (FDA)-approved medication Zavzpret is the first nasal spray-formulated CGRP receptor antagonist for acute treatment of migraine, offering rapid pain relief
-
Diversity and inclusion in clinical trials: keeping up momentum
Conducting audience research to understand the real-world audience – their day-to-day lives, pain points, motivators and barriers to taking part in a clinical trial.
-
Point.1 – HCP data with purpose and perception
It turned the world upside down and caused a lot of loss and pain.
More from intelligence
Approximately 0 fully matching, plus 124 partially matching documents found.
Latest appointments
-
Sandra Carey takes on global president, expert audiences role at McCann Health
She has also been a practising pharmacist and practitioner for most of her career, working as a clinical pharmacist in a family practice setting, running diabetes and pain management clinics and
-
New faces at HCA, P\S\L Group and Health Unlimited
I’m delighted to have the opportunity to be joining RxY. This offering is truly unique in our industry, filling a void that has long been a pain point for brand
-
Lilly strengthens team with in-house promotions
Importantly, this team will help us maintain focus as we work to bring forward new medicines in diabetes, cancer, immunology, neurodegeneration and pain.”.
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.
-
NDA bolsters its senior team
therapeutic areas including pain, as well as consumer experience.
More from appointments
Approximately 1 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
Gender biases in estimation of others’ pain. J Pain. 2021; 22(9):1048-1059. ... Accessed November 9, 2021. Marsh S. ‘I was told to live with it’: women tell of doctors dismissing their pain.
-
Isolation in the internet age
It’s not about ‘downing tools’, it’s about finding balance. After all, as the old saying goes, “he that never labours may know the pains of idleness, but not the
-
Pain Knows No Colour
Not relief from the pain, but relief for finally being seen and heard. ... There is institutional and systemic racial bias in managing and treating pain reported by Black patients.
-
Top 10 Benefits of Virtual Advisory Boards
However, it would be foolish to ignore the many pain points associated with traditional key opinion leader (KOL) engagement.
-
Case study: How we provided in-depth knowledge of electrosurgical generators among target segments and settings in the US market
Find out how we helped our client to identify clinician roles and responsibilities, pain points and drivers and barriers with respect to a current medical device. ... With a constant rise in demand for minimally viable products and efficiencies across
More from PMHub
Approximately 3 fully matching, plus 90 partially matching documents found.
Subscribe to our email news alerts
- World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future
- No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards
- Building trust with HCPs: 6 takeaways from our industry webinar
- Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
- NHS to offer stem cell transplants to patients living with rare blood disorder
- First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
No results were found
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
